Calponin 3 promotes invasion and drug resistance of colon cancer cells

doi:10.4251/wjgo.v11.i11.971

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8103)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

418

WORD

253

HTML

3202

Figures (1-4)

277

Tables (1-1)

172

Sum=4322

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

560

Download

621

Sum=1181

Publishing Process of This Article

Item

Count

Browse

898

Download

1702

Sum=2600

Nov 15, 2019 (publication date) through Aug 28, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Nov 15, 2019; 11(11): 971-982
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.971

Full Size Figure Download Figure

Figure 3 Effects of CNN3 silencing in the SW620 metastatic colon line in response to standard chemotherapeutic 5-fluorouracil and on the proteome profiles of 45 proteins. A: Response to standard chemotherapeutic 5-fluorouracil; B: Proteome profile changes. Only the consistent/significant changes observed in two repetitions are included in the graph. CNN3: Calponin 3.

Citation: Nair VA, Al-khayyal NA, Sivaperumal S, Abdel-Rahman WM. Calponin 3 promotes invasion and drug resistance of colon cancer cells. World J Gastrointest Oncol 2019; 11(11): 971-982
URL: https://www.wjgnet.com/1948-5204/full/v11/i11/971.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i11.971